Overview
- The PIPE covers 212,000,000 shares at $1.00 each, an 11.5% premium to Nov. 21’s close, with funding in U.S. dollars and USDT and BTIG as placement agent.
- Enlivex intends to accumulate RAIN as its primary reserve asset, positioning itself as the first U.S.-traded public company offering investors exposure to prediction markets.
- The transaction is expected to close on or before Nov. 25 subject to customary conditions, and Matteo Renzi’s board appointment will follow the closing.
- RAIN, the token of a permissionless prediction and options protocol on Arbitrum with a buyback-and-burn model, jumped roughly 100–120% after the news, according to market reports.
- Alongside the financing plan, Enlivex reported six‑month Phase 2a Allocetra data showing sustained pain reduction and improved function versus placebo in older knee osteoarthritis patients.